ICMR Patent Mitra I2I Connect: Biomedical Tech Transfer
Why in the news
ICMR unveiled a platform in New Delhi to narrow the gap between laboratory research and market-ready health products, by helping ICMR institutes, universities and startups hand their technologies to industry for large-scale manufacture and public use.
Key facts
- Name: Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect.
- Launched by: Indian Council of Medical Research, in New Delhi.
- Billing: India’s largest biomedical innovation and technology transfer platform.
- Showcase: over 100 Indian technologies in diagnostics, therapeutics, vaccines and medical devices.
- IP outputs: Indian Biomedical Patent Landscape Report and a Technology Compendium.
Objectives
| Goal | Meaning |
|---|---|
| Link research and industry | Move lab technologies into commercial production |
| Affordable healthcare | Lower costs through indigenous manufacturing |
| Stronger IP ecosystem | Support patent filing, protection and licensing |
| Public-private partnership | One platform for researchers, startups and industry |
| Viksit Bharat 2047 | Innovation-led, self-reliant health economy |
Diseases covered by showcased technologies
- Typhoid and paratyphoid, tuberculosis and Japanese Encephalitis.
- Mpox, Kyasanur Forest Disease (tick-borne, linked to Karnataka and the Western Ghats) and Chandipura virus (outbreaks in Gujarat and other states).
About ICMR
- Apex body for formulating, coordinating and promoting biomedical research, under the Department of Health Research, MoHFW; headquartered in New Delhi.
- Began in 1911 as the Indian Research Fund Association; renamed ICMR in 1949.
- Runs about 27 national institutes and six Regional Medical Research Centres.
Exam angle
- Platform: Patent Mitra I2I Connect; launched by ICMR.
- ICMR: founded 1911 as IRFA, renamed 1949, under the Department of Health Research.
- Reports released: Indian Biomedical Patent Landscape Report, Technology Compendium.